TY - JOUR
T1 - Activation and activity of glycosylated KLKs 3, 4 and 11
AU - Guo, Shihui
AU - Briza, Peter
AU - Magdolen, Viktor
AU - Brandstetter, Hans
AU - Goettig, Peter
N1 - Publisher Copyright:
© 2018 Shihui Guo et al., published by De Gruyter, Berlin/Boston.
PY - 2018/9/25
Y1 - 2018/9/25
N2 - Human kallikrein-related peptidases 3, 4, 11, and KLK2, the activator of KLK3/PSA, belong to the prostatic group of the KLKs, whose major physiological function is semen liquefaction during the fertilization process. Notably, these KLKs are upregulated in prostate cancer and are used as clinical biomarkers or have been proposed as therapeutic targets. However, this potential awaits a detailed characterization of these proteases. In order to study glycosylated prostatic KLKs resembling the natural proteases, we used Leishmania (LEXSY) and HEK293 cells for secretory expression. Both systems allowed the subsequent purification of soluble pro-KLK zymogens with correct propeptides and of the mature forms. Periodic acid-Schiff reaction, enzymatic deglycosylation assays, and mass spectrometry confirmed the glycosylation of these KLKs. Activation of glycosylated pro-KLKs 4 and 11 turned out to be most efficient by glycosylated KLK2 and KLK4, respectively. By comparing the glycosylated prostatic KLKs with their non-glycosylated counterparts from Escherichia coli, it was observed that the N-glycans stabilize the KLK proteases and change their activation profiles and their enzymatic activity to some extent. The functional role of glycosylation in prostate-specific KLKs could pave the way to a deeper understanding of their biology and to medical applications.
AB - Human kallikrein-related peptidases 3, 4, 11, and KLK2, the activator of KLK3/PSA, belong to the prostatic group of the KLKs, whose major physiological function is semen liquefaction during the fertilization process. Notably, these KLKs are upregulated in prostate cancer and are used as clinical biomarkers or have been proposed as therapeutic targets. However, this potential awaits a detailed characterization of these proteases. In order to study glycosylated prostatic KLKs resembling the natural proteases, we used Leishmania (LEXSY) and HEK293 cells for secretory expression. Both systems allowed the subsequent purification of soluble pro-KLK zymogens with correct propeptides and of the mature forms. Periodic acid-Schiff reaction, enzymatic deglycosylation assays, and mass spectrometry confirmed the glycosylation of these KLKs. Activation of glycosylated pro-KLKs 4 and 11 turned out to be most efficient by glycosylated KLK2 and KLK4, respectively. By comparing the glycosylated prostatic KLKs with their non-glycosylated counterparts from Escherichia coli, it was observed that the N-glycans stabilize the KLK proteases and change their activation profiles and their enzymatic activity to some extent. The functional role of glycosylation in prostate-specific KLKs could pave the way to a deeper understanding of their biology and to medical applications.
KW - N-linked glycosylation
KW - enzyme kinetics
KW - eukaryotic expression
KW - prostate cancer biomarker
KW - zymogen activation
UR - http://www.scopus.com/inward/record.url?scp=85049724460&partnerID=8YFLogxK
U2 - 10.1515/hsz-2018-0148
DO - 10.1515/hsz-2018-0148
M3 - Article
C2 - 29975661
AN - SCOPUS:85049724460
SN - 1431-6730
VL - 399
SP - 1009
EP - 1022
JO - Biological Chemistry
JF - Biological Chemistry
IS - 9
ER -